Synthesis and Educational Overview of the ASCO-Society of Integrative Oncology Guidelines: On the Path to Implementation [0.03%]
ASCO-整合肿瘤学学会指南的合成与教育概览：走向实施之路
Krisstina Gowin,Eugene R Ahn,Ana Maria Lopez
Krisstina Gowin
Cancer care is rapidly changing. Advances in treatments therapeutics, such as gene and immunotherapies, have revolutionized patient outcomes and given new hope to survivors and cosurvivors. Despite these advances, disease- and treatment-rel...
Icro Meattini,Ana Tecic Vuger,Carlotta Becherini et al.
Icro Meattini et al.
The excellent cure rates documented in clinical trials today constitute a very high bar for attempts to de-escalate therapy for early-stage breast cancer (EBC). Moreover, any therapy de-escalation must be made in the context of an optimal m...
After a CDK4/6 Inhibitor: State of the Art in Hormone Receptor-Positive Metastatic Breast Cancer [0.03%]
CDK4/6抑制剂之后激素受体阳性转移性乳腺癌的治疗进展
Jimmitti Teysir,Maxwell R Lloyd,Samer Alkassis et al.
Jimmitti Teysir et al.
CDK 4/6 inhibitors (CDK4/6i) remain part of the standard first-line treatment for patients with hormone receptor-positive metastatic breast cancer, offering demonstrable improvements in both progression-free survival and overall survival. H...
Global Oncology: Tackling Disparities and Promoting Innovations in Low- and Middle-Income Countries [0.03%]
全球肿瘤学：应对低收入和中等收入国家的差异并促进创新
Regina Barragan-Carillo,Fredrick Chite Asirwa,Rodrigo Dienstmann et al.
Regina Barragan-Carillo et al.
Global cancer incidence is projected to rise dramatically, with over 35 million new cases anticipated by 2050, disproportionately affecting low- and middle-income countries (LMICs) where up to 70% of cancer deaths are expected to occur. Thi...
Proposed Policy Changes to Cancer Care and Oncologic Drug Reimbursement: Exploring the Rationale and Anticipating the Consequences [0.03%]
我国癌症治疗及抗癌药物报销政策变革探析：理由与后果
Ryan W Huey,Joshua C Pritchett,Kerstin N Vokinger et al.
Ryan W Huey et al.
Although innovation in cancer treatment has improved cure rates and survival, the costs have escalated beyond societies' ability to pay. Cancer care costs in the United States are expected to rise to 245 billion by 2030. In this health poli...
Erin L Price,Shanda H Blackmon,Reshma Jagsi
Erin L Price
Distress and isolation frequently affect individuals with cancer and oncology care providers. Both oncology care teams and patient communities play a crucial role in offering support during challenging times. These networks help individuals...
Surgical and Perioperative Advances for Patients With Locally Advanced Non-Small Cell Lung Cancer [0.03%]
局部晚期非小细胞肺癌患者的外科和围手术期进展
Anne Opalikhin,Scott Friedland,Maria Lucia Madariaga et al.
Anne Opalikhin et al.
Locally advanced non-small cell lung cancer (NSCLC) is primarily treated with multimodality therapy, which has undergone significant advancements over the years. Recently, the management of resectable NSCLC has evolved to provide patients m...
Implementation Science as the Secret Sauce for Integrating Exercise Screening and Triage Pathways in Oncology [0.03%]
实施科学在肿瘤学中整合运动筛查和分诊路径的隐秘秘诀
Prajakta Adsul,Mackenzi Pergolotti,Kathryn H Schmitz
Prajakta Adsul
Oncology rehabilitation and exercise (ORE) exist along a continuum of care, providing essential services for patients with cancer to improve health outcomes. Although oncology rehabilitation, typically delivered by licensed medical professi...
Nicholas Hornstein,Jacob Levenson,Toshihiro Nakayama et al.
Nicholas Hornstein et al.
Resection of liver metastases is considered the only treatment with curative potential for patients with metastatic colorectal cancer to the liver (CRLM). However, only a minority of patients with CRLM are eligible for up-front resection of...
Management of Cutaneous Melanoma, With a Special Focus on Desmoplastic Melanoma [0.03%]
黑色素瘤的诊疗述评——以皮质颗粒性 melanoma 为重点
Kari L Kendra,Carlo M Contreras,Claire F Verschraegen et al.
Kari L Kendra et al.
Not all melanomas are the same. They differ in presentation, mutational status, and behavior. Desmoplastic melanoma (DM) is a rare subtype of melanoma which carries a high tumor mutation burden and is found in highly sun-exposed areas. Alth...